Evidence map›Paper›PMID 32557555›Full record

ArticleBritish journal of haematology2020

Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia.

Julien Favresse, Christine Eucher, Marc Elsen, Carlos Graux, Paul Goebels, Kim Laffineur, Jean-Baptiste Nicolas, Jean-Michel Dogné, Jonathan Douxfils

Abstract readLetterComment
In one paragraph

Article in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Transient disappearance of CD19Clinical case reports · 2021
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Julien FavresseDepartment of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.ORCID 0000-0002-9805-049X
Christine EucherDepartment of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.
Marc ElsenDepartment of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.
Carlos GrauxDepartment of Hematology, CHU UCL Namur, Yvoir, Belgium.
Paul GoebelsDepartment of Laboratory Medicine, Saint Nikolaus Hospital, Eupen, Belgium.
Kim LaffineurDepartment of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.
Jean-Baptiste NicolasDepartment of Internal Medicine, Clinique St-Luc Bouge, Namur, Belgium.
Jean-Michel DognéDepartment of Pharmacy, Namur Research Institute for LIfes Sciences, University of Namur, Namur, Belgium.
Jonathan DouxfilsDepartment of Pharmacy, Namur Research Institute for LIfes Sciences, University of Namur, Namur, Belgium.ORCID 0000-0002-7644-5298

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Leukemia, Lymphocytic, Chronic, B-CellAntibodies, ViralHospitalsHumansKineticsPandemicsSARS-CoV-2Antibodies, ViralCOVID-19kineticsSARS-CoV-2serologysymptom onset

Identifiers

PMID32557555
PMCPMC7323137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.